Selected article for: "coronavirus infection and increase risk"
Author: Mottola, Filiberto Fausto; Verde, Nicoletta; Ricciolino, Riccardo; Di Mauro, Marco; Migliaccio, Marco Giuseppe; Carfora, Vincenzo; Spiniello, Giorgio; Coppola, Nicola
Title: Cardiovascular System in COVID-19: Simply a Viewer or a Leading Actor?
  • Cord-id: cjq7szcn
  • Document date: 2020_8_27
    • ID: cjq7szcn
    Snippet: As of January 2020, a new pandemic has spread from Wuhan and caused thousands of deaths worldwide. Several studies have observed a relationship between coronavirus disease (COVID-19) infection and the cardiovascular system with the appearance of myocardial damage, myocarditis, pericarditis, heart failure and various arrhythmic manifestations, as well as an increase in thromboembolic risk. Cardiovascular manifestations have been highlighted especially in older and more fragile patients and in tho
    Document: As of January 2020, a new pandemic has spread from Wuhan and caused thousands of deaths worldwide. Several studies have observed a relationship between coronavirus disease (COVID-19) infection and the cardiovascular system with the appearance of myocardial damage, myocarditis, pericarditis, heart failure and various arrhythmic manifestations, as well as an increase in thromboembolic risk. Cardiovascular manifestations have been highlighted especially in older and more fragile patients and in those with multiple cardiovascular risk factors such as cancer, diabetes, obesity and hypertension. In this review, we will examine the cardiac involvement associated with SARS-CoV-2 infection, focusing on the pathophysiological mechanism underlying manifestations and their clinical implication, taking into account the main scientific papers published to date.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute cardiac injury: 1, 2
    • ace inhibitor and acute coronary: 1, 2, 3
    • ace inhibitor and acute coronary syndrome: 1
    • ace inhibitor and acute heart failure: 1
    • ace inhibitor and acute infection: 1, 2, 3, 4, 5
    • ace inhibitor and acute kidney injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • ace polymorphism and acute ards respiratory distress syndrome: 1, 2, 3
    • ace polymorphism and acute infection: 1
    • ace polymorphism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11